Effects of age on aerobic capacity in heart failure patients under beta-blocker therapy: Possible impact in clinical decision-making?

Cardiology Journal

Volumn 20, Issue 6, 2013, Pages 655-661

  Ciolac, Emmanuel Gomes ^a   Bocchi, Edimar Alcides ^b   Fernandes da Silva, Miguel Morita ^b   Tavares, Aline Cristina ^b   Teixeira Neto, Iram Soares ^b   Guimarães, Guilherme Veiga ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

blocker therapy; Aging; Cardiopulmonary exercise test; Cardiorespiratory fitness; Heart failure

Indexed keywords

ALDOSTERONE; AMRINONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARBON DIOXIDE; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; NITRATE;

ADULT; AEROBIC CAPACITY; AGE; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL DECISION MAKING; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; LUNG GAS EXCHANGE; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; RETROSPECTIVE STUDY; TREADMILL EXERCISE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DECISION SUPPORT TECHNIQUES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84890350601     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.2013.0166     Document Type: Article

References (27)

1. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds H, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation, 1991; 83: 778-786.
2. Carvalho VO. Bocchi EA. Guimarães GV. The Carvedilol's beta--blockade in heart failure and exercise training's sympathetic blockade in healthy athletes during the rest and peak effort. Cardiovascular Therapeutics, 2010; 28: 87-92.
3. Puntawangkoon C, Kitzman DW, Kritchevsky SB et al. Reduced peripheral arterial blood flow with preserved cardiac output during submaximal bicycle exercise in elderly heart failure. J Cardiovasc Magn Resonance, 2009; 18: 11-48.
4. Bocchi EA, Cruz F, Guimarães G et al. Long-term prospective, randomized, controlled study using repetitive education at six--month intervals and monitoring for adherence in heart failure outpatients: the REMADHE trial. Circ Heart Fail, 2008; 1: 115-124.
5. Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A. Nomogram based on metabolic equivalents and age for assessing aerobic exercise capactiy in men. J Am Coll Cardiol, 1993; 22: 175-182.
6. Myers J, Gullestad L, Vagelos R et al. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med, 1998; 129: 286-293.
7. Jaussaud J, Aimable L, Douard H. The time for a new strong functional parameter in heart failure: the VE/VCO2slope. Int J Cardiol, 2011; 147: 189-190.
8. Kokkinos P. Myers J. Faselis C et al. Exercise capacity and mortality in older men. A 20-year follow-up study. Circulation, 2010; 122: 790-797.
9. Guimaraes GV, d'Avila VM, Silva MS et al. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with beta-blocker therapy. Int J Cardiol, 2010; 145: 75-77.
10. Oxenham H, Sharpe N. Cardiovascular aging and heart failure. Eur J Heart Fail, 2003; 5: 427-434.
11. Priebe HJ. The aged cardiovascular risk patient. Br J Anaesth, 2000; 85: 763-778.
12. 2max. J Appl Physiol, 1988; 65: 1147-1151.
13. Hawkins AS, Wiswell RA. Rate and mechanism of maximal oxygen consuption decline with aging. Implication for exercise training. Sports Med, 2003; 33: 877-888.
14. Fletcher GF, Balady GJ, Amsterdam EA et al. Exercise standards for testing and training: A statement for healthcare professionals from the American Heart Association. Circulation, 2001; 104: 1694-740.
15. Forman DE, Clare R, Kitzman DW et al. Relationship of age and exercise performance in patients with heart failure: The HF-ACTION study. Am Heart J, 2009; 158: S6-S15.
16. Arena R, Myers J, Abella J et al. Cardiopulmonary exercise testing is equally prognostic in young, middle-aged and older individuals diagnosed with heart failure. Int J Cardiol, 2010; 151: 278-283.
17. Ciolac EG, Bocchi EA, Bortolotto LA, Carvalho VO, Greve JM, Guimaraes GV. Hemodynamic, metabolic, and neuro-humoralabormalities in young normotensive women at high familial risk for hypertension. J Hum Hypertens, 2010; 24: 814-822.
18. th Ed. Lippincott Williams and Wilkins, Philadelphia 2004: 160-182.
19. Brawner CA, Ehrman JK, Schairer JR, Cao JJ, Keteyian SJ. Predicting maximum heart rate among patients with coronary heart disease receiving beta-adrenergic blockade therapy. Am Heart J, 2004; 148: 910-914.
20. Tanaka H. Habitual exercise for the elderly. Fam Community Health, 2009; 32 (1 Suppl.): S57-S65.
21. Fleg JL, Morrell CH, Bos AG et al. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation, 2005; 112: 674-682.
22. Guimarães GV, Silva MSV, d'Avila VM, Ferreira SMA, Silva CP, Bocchi EA. Peak VO2 and VE/VCO2 slope in beta-blockers era in patients with heart failure: a Brazilian experience. Arq Bras Cardiol, 2008; 91: 39-45.
23. Hawkins SA, Wiswell RA. Rate and mechanism of maximal oxygen consumption decline with aging. Sports Med, 2003; 33: 877-888.
24. Lainscak M, Moullet C, Schon N, Tendera M. Treatment of chronic heart failure with carvedilol in daily practice: The SATELLITE survey experience. Int J Cardiol, 2007; 122: 149-155.
25. Carvalho VO, Rodrigues Alves RX, Bocchi EA, Guimarães GV. Heart rate dynamic during an exercise test in heart failure patients with different sensibilities of the carvedilol therapy: heart rate dynamic during exercise test. Int J Cardiol, 2010; 142: 101-104.
26. Fernandes Silva MM, Bacal F, Roque JM et al. Age-related maximum heart rate among ischemic and nonischemic heart failure patients receiving b-blockade therapy. J Card Fail, 2012; 18: 831-836.
27. Richards DR, Mehra MR, Ventura HO et al. Usefulness of peak oxygen consumption in predicting outcome of heart failure in women versus men. Am J Cardiol, 1997; 80: 1236-1238.